Insider transactions

EDGAR

CRYOPORT, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
16 transactions, 412,329 shares
Sum of shares × price per share: 6,341,418.4286

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–49 of 49

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-10 Filed 2026-11-12Sawicki Mark W Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,00019.9261
199,261

Derived: shares × price per share. Exact value 199261.0000.

92,356Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $20.27, inclusive.
Open filing 0001104659-26-126370 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)30,0009.73
291,900

Derived: shares × price per share. Exact value 291900.00.

99,052Direct (D) Yes
F1
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)23,83012.65
301,449.5

Derived: shares × price per share. Exact value 301449.50.

122,882Direct (D) Yes
F1
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20,5497.00
143,843

Derived: shares × price per share. Exact value 143843.00.

143,431Direct (D) Yes
F1
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)74,37920.207
1,502,976.453

Derived: shares × price per share. Exact value 1502976.453.

69,052Direct (D) Yes
F1, F2
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.47, inclusive.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (30,000) — exercise price 9.73
Disposed (D)30,0000.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) Yes
F1, F3
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
  • F3 1/36 of the options vested on the 4th of each month for thirty-six months beginning on 1/4/2019.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (23,830) — exercise price 12.65
Disposed (D)23,8300.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) Yes
F1, F4
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
  • F4 1/12 of the options vested on the 17th of the month for twelve months beginning 6/17/2024.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12HANCOCK DANIEL M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (20,549) — exercise price 7.00
Disposed (D)20,5490.00
0

Derived: shares × price per share. Exact value 0.00.

20,549Direct (D) Yes
F1, F5
  • F1 This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
  • F5 1/12 of the options vested on the 6th of the month for twelve months beginning 7/6/2025.
Open filing 0001104659-26-126367 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-11SHELTON JERRELL Director · Officer: President, CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)28,80014.9092
429,384.96

Derived: shares × price per share. Exact value 429384.9600.

1,201,814Direct (D) Yes
F1, F2
  • F1 The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001104659-26-094228 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)33,6004.80
161,280

Derived: shares × price per share. Exact value 161280.00.

143,319Direct (D) No— Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)33,60014.4714
486,239.04

Derived: shares × price per share. Exact value 486239.0400.

109,719Direct (D) No
F2
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive.
Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (33,600) — exercise price 4.80
Disposed (D)33,6000—0Direct (D) No
F3
  • F3 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.
Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,4004.80
6,720

Derived: shares × price per share. Exact value 6720.00.

111,119Direct (D) No— Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,40015.2314
21,323.96

Derived: shares × price per share. Exact value 21323.9600.

109,719Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive.
Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-12ZECCHINI EDWARD J Officer: Chief Digital and Tech Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (1,400) — exercise price 4.80
Disposed (D)1,4000—33,600Direct (D) No
F3
  • F3 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.
Open filing 0001104659-26-073630 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-08Mandalam Ramkumar Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,21415.4412
358,452.0168

Derived: shares × price per share. Exact value 358452.0168.

67,894Direct (D) No
F2
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001104659-26-071506 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-09BADDOUR LINDA Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,3500—68,099Direct (D) No
F1
  • F1 Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
Open filing 0001104659-26-071724 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-09BADDOUR LINDA Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy Common Stock) — underlying Common Stock (16,077) — exercise price 15.7
Acquired (A)16,0770—16,077Direct (D) No
F2
  • F2 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Open filing 0001104659-26-071724 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Mandalam Ramkumar Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,3500—91,108Direct (D) No
F1
  • F1 Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
Open filing 0001104659-26-071506 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Mandalam Ramkumar Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy Common Stock) — underlying Common Stock (16,077) — exercise price 15.7
Acquired (A)16,0770—16,077Direct (D) No
F3
  • F3 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Open filing 0001104659-26-071506 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08HANCOCK DANIEL M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,3500—69,052Direct (D) No
F1
  • F1 Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
Open filing 0001104659-26-071508 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08HANCOCK DANIEL M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy Common Stock) — underlying Common Stock (16,077) — exercise price 15.7
Acquired (A)16,0770—16,077Direct (D) No
F2
  • F2 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Open filing 0001104659-26-071508 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Hariri Robert J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)10,3500—61,625Direct (D) No
F1
  • F1 Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
Open filing 0001104659-26-071507 Read from the filing’s XML Dispute this row
2026-06-05 Filed 2026-06-08Hariri Robert J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy Common Stock) — underlying Common Stock (16,077) — exercise price 15.7
Acquired (A)16,0770—16,077Direct (D) No
F2
  • F2 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Open filing 0001104659-26-071507 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-08STEFANOVICH ROBERT Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)169,42716.2724
2,756,983.9148

Derived: shares × price per share. Exact value 2756983.9148.

109,850Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001104659-26-071509 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-23SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)104,0071.87
194,493.09

Derived: shares × price per share. Exact value 194493.09.

1,230,614Direct (D) No— Open filing 0001104659-26-047945 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-23SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Options to purchase common stock — underlying Common Stock (104,007) — exercise price 1.87
Disposed (D)104,0070—0Direct (D) No
F1
  • F1 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
Open filing 0001104659-26-047945 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)50,0001.87
93,500

Derived: shares × price per share. Exact value 93500.00.

1,126,607Direct (D) No— Open filing 0001104659-26-041041 Read from the filing’s XML Dispute this row
2026-04-06 Filed 2026-04-08SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Options to purchase common stock — underlying Common Stock (50,000) — exercise price 1.87
Disposed (D)50,0000—104,007Direct (D) No
F1
  • F1 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
Open filing 0001104659-26-041041 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25SHELTON JERRELL Director · Officer: President, CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,8948.18
23,672.92

Derived: shares × price per share. Exact value 23672.92.

1,051,607Direct (D) No
F1
  • F1 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-034753 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,0001.87
46,750

Derived: shares × price per share. Exact value 46750.00.

1,076,607Direct (D) No— Open filing 0001104659-26-034753 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25SHELTON JERRELL Director · Officer: President, CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Options to purchase common stock — underlying Common Stock (25,000) — exercise price 1.87
Disposed (D)25,0000—154,007Direct (D) No
F2
  • F2 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
Open filing 0001104659-26-034753 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25Sawicki Mark W Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,3418.18
10,969.38

Derived: shares × price per share. Exact value 10969.38.

102,356Direct (D) No
F1
  • F1 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-034752 Read from the filing’s XML Dispute this row
2026-03-23 Filed 2026-03-25STEFANOVICH ROBERT Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,0948.18
8,948.92

Derived: shares × price per share. Exact value 8948.92.

279,277Direct (D) No
F1
  • F1 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-034754 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-17Sawicki Mark W Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,2358.00
25,880

Derived: shares × price per share. Exact value 25880.00.

103,697Direct (D) No
F2
  • F2 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-029718 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-17ZECCHINI EDWARD J Officer: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,0148.00
16,112

Derived: shares × price per share. Exact value 16112.00.

109,719Direct (D) No
F2
  • F2 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-029720 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-17SHELTON JERRELL Director · Officer: President, CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,9188.00
63,344

Derived: shares × price per share. Exact value 63344.00.

1,054,501Direct (D) No
F1
  • F1 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-029719 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,7438.00
21,944

Derived: shares × price per share. Exact value 21944.00.

280,371Direct (D) No
F4
  • F4 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-17Sawicki Mark W Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)22,8450—106,932Direct (D) No
F1
  • F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
Open filing 0001104659-26-029718 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-17Sawicki Mark W Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (68,534) — exercise price 8.60
Acquired (A)68,5340—68,534Direct (D) No
F3
  • F3 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Open filing 0001104659-26-029718 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-17ZECCHINI EDWARD J Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,3220—111,733Direct (D) No
F1
  • F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
Open filing 0001104659-26-029720 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-17ZECCHINI EDWARD J Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (63,965) — exercise price 8.60
Acquired (A)63,9650—63,965Direct (D) No
F3
  • F3 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Open filing 0001104659-26-029720 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-17SHELTON JERRELL Director · Officer: President, CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (492,901) — exercise price 8.60
Acquired (A)492,9010—492,901Direct (D) No
F2
  • F2 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Open filing 0001104659-26-029719 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)27,4130—283,114Direct (D) No
F3
  • F3 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2026-03-14 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (82,240) — exercise price 8.60
Acquired (A)82,2400—82,240Direct (D) No
F6
  • F6 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)87,1881.87
163,041.56

Derived: shares × price per share. Exact value 163041.56.

294,401Direct (D) No— Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)38,7007.7619
300,385.53

Derived: shares × price per share. Exact value 300385.5300.

255,701Direct (D) No
F1, F2
  • F1 The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.
Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-16STEFANOVICH ROBERT Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Options to purchase common stock — underlying Common Stock (87,188) — exercise price 1.87
Disposed (D)87,1880—0Direct (D) No
F5
  • F5 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
Open filing 0001104659-26-028775 Read from the filing’s XML Dispute this row
2025-12-10 Filed 2025-12-12Mandalam Ramkumar Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,5709.9862
115,540.334

Derived: shares × price per share. Exact value 115540.3340.

80,758Direct (D) No
F1
  • F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.93 to $10.0696, inclusive.
Open filing 0001104659-25-120727 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–6 of 6

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
HRT FINANCIAL LP 450,000 SH7,829 dollarsUnchanged Prior quarter: 450,000Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
IMC-Chicago, LLC Option: Call 77,100 SH1,341,540 dollarsHigher by 700 Prior quarter: 76,400Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
GROUP ONE TRADING LLC Option: Call 61,200 SH1,064,880 dollarsHigher by 700 Prior quarter: 60,500Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
SIMPLEX TRADING, LLC Option: Call 49,300 SH857,820 dollarsHigher by 24,300 Prior quarter: 25,000Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
SIMPLEX TRADING, LLC Option: Put 15,200 SH264,479 dollarsHigher by 12,300 Prior quarter: 2,900Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
IMC-Chicago, LLC Option: Put 11,200 SH194,880 dollarsHigher by 300 Prior quarter: 10,900Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–20 of 20

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Josh Gottheimer (NJ05)2023-09-15Sale$1,001 - $15,000JT2023-10-15
Hon. Donald Sternoff Beyer Jr. (VA08)2022-02-28Sale$1,001 - $15,000JT2022-03-03
Hon. Donald Sternoff Beyer Jr. (VA08)2022-01-31Sale$1,001 - $15,000JT2022-02-01
Hon. Donald Sternoff Beyer Jr. (VA08)2022-01-13Sale$1,001 - $15,000JT2022-02-01
Hon. Donald Sternoff Beyer Jr. (VA08)2022-01-14Sale$1,001 - $15,000JT2022-02-01
Hon. Donald Sternoff Honorable Beyer Jr (VA08)2021-09-21Sale$1,001 - $15,000JT2021-10-01
Hon. Gilbert Cisneros (CA39)2020-11-24Sale (partial)$1,001 - $15,0002020-12-15
Hon. Josh Gottheimer (NJ05)2020-11-13Sale (partial)$1,001 - $15,000JT2020-12-09
Hon. Donald Sternoff Beyer Jr (VA08)2020-11-02Purchase$1,001 - $15,000JT2020-12-01
Hon. Donald Sternoff Beyer Jr (VA08)2020-11-17Purchase$1,001 - $15,000JT2020-12-01
Hon. Donald Sternoff Beyer Jr (VA08)2020-07-14Sale$1,001 - $15,000JT2020-08-09
Hon. Donald Sternoff Beyer Jr (VA08)2020-05-07Sale$1,001 - $15,000JT2020-05-31
Hon. Gilbert Cisneros (CA39)2020-02-06Purchase$1,001 - $15,0002020-03-10
Hon. Donald Sternoff Beyer Jr (VA08)2020-01-13Purchase$1,001 - $15,000JT2020-02-22
Hon. Donald Sternoff Beyer Jr (VA08)2020-02-18Purchase$1,001 - $15,000JT2020-02-22
Hon. Gilbert Cisneros (CA39)2020-01-17Purchase$1,001 - $15,0002020-02-18
Hon. Josh Gottheimer (NJ05)2020-01-14Purchase$1,001 - $15,000JT2020-02-10
Hon. Donald Sternoff Beyer Jr (VA08)2019-12-23Purchase$1,001 - $15,000JT2020-01-02
Hon. Donald Sternoff Beyer Jr (VA08)2019-11-19Purchase$1,001 - $15,000JT2019-12-14
Hon. Donald Sternoff Beyer Jr (VA08)2019-11-25Purchase$1,001 - $15,000JT2019-12-14

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Cadian Capital Management, LP Common Stock, par value $0.001 per share4.82,418,94709/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001011438-26-000723 Dispute this row
Cadian Capital Management GP, LLC Common Stock, par value $0.001 per share4.82,418,94709/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001011438-26-000723 Dispute this row
Eric Bannasch Common Stock, par value $0.001 per share4.82,418,94709/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001011438-26-000723 Dispute this row
Cadian Capital Management, LP Common Stock, par value $0.001 per share5.82,920,68106/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001011438-26-000542 Dispute this row
Cadian Capital Management GP, LLC Common Stock, par value $0.001 per share5.82,920,68106/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001011438-26-000542 Dispute this row
ERIC BANNASCH Common Stock, par value $0.001 per share5.82,920,68106/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001011438-26-000542 Dispute this row
Morgan Stanley Common Stock4.52,246,65006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000261 Dispute this row
Morgan Stanley Capital Services LLC Common Stock4.32,163,38406/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0000895421-26-000261 Dispute this row
Integrated Core Strategies (US) LLC Common Stock, par value $0.001 per share3.11,556,718.0006/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-088284 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share3.41,724,726.0006/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-088284 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share3.41,724,726.0006/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-088284 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share3.41,724,726.0006/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-088284 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 7Open filing 0000102909-26-001051 Dispute this row
Brown Capital Management, LLC Common Stock, Par Value $0.01 Per Share2.21,112,771.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 9Open filing 0001398344-26-003306 Dispute this row
Integrated Core Strategies (US) LLC Common Stock, par value $0.001 per share6.53,231,470.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-011041 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share6.53,244,802.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-011041 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share6.53,244,802.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-011041 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share6.53,244,802.0012/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-011041 Dispute this row
Brown Capital Management, LLC Common Stock, Par Value $0.01 Per Share5.242,621,844.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 8Open filing 0001398344-25-020765 Dispute this row
Integrated Core Strategies (US) LLC Common Stock, par value $0.001 per share5.12,555,766.0009/24/2025 Filed 2025-09-26SCHEDULE 13GOpen filing 0001104659-25-093876 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share5.12,562,717.0009/24/2025 Filed 2025-09-26SCHEDULE 13GOpen filing 0001104659-25-093876 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share5.12,562,717.0009/24/2025 Filed 2025-09-26SCHEDULE 13GOpen filing 0001104659-25-093876 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share5.12,562,717.0009/24/2025 Filed 2025-09-26SCHEDULE 13GOpen filing 0001104659-25-093876 Dispute this row
Alger Associates, Inc. Common Stock4.72,358,94006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0000950170-25-108978 Dispute this row
Brown Capital Management, LLC Common Stock, Par Value $0.01 Per Share7.583,798,962.0006/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 7Open filing 0001398344-25-015332 Dispute this row
Integrated Core Strategies (US) LLC Common Stock, par value $0.001 per share4.42,212,571.0006/30/2025 Filed 2025-08-05SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-074214 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share4.42,212,571.0006/30/2025 Filed 2025-08-05SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-074214 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share4.42,212,571.0006/30/2025 Filed 2025-08-05SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-074214 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share4.42,212,571.0006/30/2025 Filed 2025-08-05SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-074214 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,536 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,154

Filings made before the SEC required XML are listed, not extracted.

Back to CRYOPORT, INC.